(Q64901750)

30 June 2019

title

MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10. (English)

1 reference

30 June 2019

1 reference

Haining Meng

1

1 reference

30 June 2019

Qiao Huang

2

1 reference

30 June 2019

Xijin Zhang

3

1 reference

30 June 2019

Jiawei Huang

4

1 reference

30 June 2019

Ruowu Shen

5

1 reference

30 June 2019

Bei Zhang

6

1 reference

30 June 2019

language of work or name

English

0 references

publication date

16 May 2019

1 reference

30 June 2019

published in

OncoTargets and Therapy

1 reference

30 June 2019

volume

12

1 reference

30 June 2019

page(s)

3829-3838

1 reference

30 June 2019

Creative Commons Attribution-NonCommercial 3.0 Unported

copyright license

start time

1 May 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions

1 reference

12 December 2020

The ADAMs family of metalloproteases: multidomain proteins with multiple functions

1 reference

12 December 2020

Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP.

1 reference

12 December 2020

Multidisciplinary management of lung cancer

1 reference

12 December 2020

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

12 December 2020

[Surgical treatment of non-small cell lung cancer]

1 reference

12 December 2020

ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling

1 reference

12 December 2020

Shedding light on ADAM metalloproteinases

1 reference

12 December 2020

Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma

1 reference

12 December 2020

(Make) stick and cut loose--disintegrin metalloproteases in development and disease

1 reference

12 December 2020

Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion.

1 reference

12 December 2020

Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

1 reference

12 December 2020

Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.

1 reference

12 December 2020

Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection

1 reference

12 December 2020

Hallmarks of Cancer: The Next Generation

1 reference

12 December 2020

miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.

1 reference

12 December 2020

The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.

1 reference

12 December 2020

ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway

1 reference

12 December 2020

Ectodomain shedding and ADAMs in development

1 reference

12 December 2020

MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met

1 reference

12 December 2020

miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.

1 reference

12 December 2020

Regulation of ADAM10 and ADAM17 by Sorafenib Inhibits Epithelial-to-Mesenchymal Transition in Epstein-Barr Virus-Infected Retinal Pigment Epithelial Cells

1 reference

12 December 2020

Lung Cancer Statistics

1 reference

12 December 2020

Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.

1 reference

12 December 2020

miR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma

1 reference

12 December 2020

An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth

1 reference

12 December 2020

TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production

1 reference

12 December 2020

Cancer Statistics, 2017.

1 reference

12 December 2020

The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4.

1 reference

12 December 2020

Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.

1 reference

12 December 2020

Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm.

1 reference

12 December 2020

MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway.

1 reference

12 December 2020

Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma

1 reference

12 December 2020

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis

1 reference

12 December 2020

ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker

1 reference

12 December 2020

MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway

1 reference

12 December 2020

KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition

1 reference

12 December 2020

PAX2 may induce ADAM10 expression in renal tubular epithelial cells and contribute to epithelial-to-mesenchymal transition

1 reference

12 December 2020

MiR-663a Stimulates Proliferation and Suppresses Early Apoptosis of Human Spermatogonial Stem Cells by Targeting NFIX and Regulating Cell Cycle.

1 reference

12 December 2020

miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1

1 reference

12 December 2020

LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis

1 reference

12 December 2020

Regulation of proto-oncogene Orai3 by miR18a/b and miR34a

1 reference

12 December 2020

Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198

1 reference

12 December 2020

Identifiers

DOI

10.2147/OTT.S190282

1 reference

30 June 2019

PMCID

6529029

1 reference

30 June 2019

PubMed ID

31190882

1 reference

30 June 2019